After moving 0.6% during today's evening session, Thermo Fisher Scientific is now trading at a price of $434.11 per share. On average, analysts give it a target price of $601.88.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally.
Potential Thermo Fisher Scientific Investors Should Analyze the Following:
-
Thermo Fisher Scientific has moved -15.0% over the last year.
-
The company has a price to earnings growth (PEG) ratio of 3.7. A number between 0 and 1 could mean that the market is undervaluing Thermo Fisher Scientific's estimated growth potential
-
Its Price to Book (P/B) ratio is 3.7
-
Thermo Fisher Scientific currently returns an annual dividend yield of 0.1%.
Understanding Thermo Fisher Scientific's Operating Margins
| Date Reported | Total Revenue ($ k) | Operating Expenses ($ k) | Operating Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 43,524,000 | 36,812,000 | 15 | -21.05 |
| 2022 | 44,915,000 | 36,522,000 | 19 | -26.92 |
| 2021 | 39,211,000 | 29,183,000 | 26 | 8.33 |
| 2020 | 32,218,000 | 24,424,000 | 24 | 33.33 |
| 2019 | 25,542,000 | 20,948,000 | 18 | 12.5 |
| 2018 | 24,358,000 | 20,575,000 | 16 |
Over the last 6 years, Thermo Fisher Scientific's operating margins have averaged 19.7%, which is better than the 13.8% Farm & Heavy Construction Machinery industry average. We also note that the company's operating margins have a high coefficient of variability at 127.0%. The firm's margins exhibit a relatively stable growth trend of -0.6%.
